Annovis Bio received a U.S. patent for a new crystal version of its drug, buntanetap.

ANVS · Annovis Bio, Inc.

The AI's read

This protection may help Annovis defend its lead drug if the studies succeed. But buntanetap is still being tested, and the patent does not show that it works. Trial results and later review will still matter.